EL7.AI
StocksMedium•18 November 2026•
3 min read

Oceania Healthcare’s underlying earnings rise 18% to NZ$49 million

Key Facts

1Underlying earnings before interest, tax, depreciation and amortisation rose 18% to NZ$49.0 million in the first half of fiscal 2027.
2Care earnings increased 33% to NZ$16.0 million, and care occupancy was 94.3%.
3Resale settlements totalled 200, and their total value rose 32% to NZ$122.5 million.
4Comprehensive income fell to NZ$5.3 million from NZ$40.4 million in the year-earlier period.
5Cash inflow since the start of the fiscal year rose to NZ$4.3 million through October.

Oceania Healthcare reported an 18% increase in underlying earnings before interest, tax, depreciation and amortisation to NZ$49.0 million in the first half of fiscal 2027, for the six months ended 30 September 2026. The company’s announcement was published on the New Zealand Stock Exchange at 19:30 on 18 November 2026. The company said earnings growth was 22% on a like-for-like basis, excluding sites sold during fiscal 2026. The results put improved operating performance at the forefront, with a clear divergence between growth in underlying earnings and a decline in comprehensive income. Management also highlighted cash flow as a focus for the current fiscal year.

The care segment improved, with earnings before interest, tax, depreciation and amortisation rising 33% to NZ$16.0 million. The care earnings margin increased to 16.4%, from 11.6% in the year-earlier period. Care occupancy was 94.3% at 30 September 2026. The company attributed improved cash flow to higher care earnings, alongside strong unit resales and the benefit of cost savings. Chief Executive Susan Dorfvac said the company had "generated positive cash flow from operations in the first half," adding that the focus would be on sustaining performance in the second half.

The company recorded 200 unit resale settlements, up 11% from the year-earlier period. The total value of those transactions rose 32% to NZ$122.5 million. The resale margin also widened by 2.9 percentage points to 19.9%. These figures indicate the contribution of unit sales to the improvement in the existing business during the period. The company said stronger resales, along with growth in care earnings and cost savings, also drove improved cash flow.

By contrast, comprehensive income fell to NZ$5.3 million from NZ$40.4 million in the year-earlier period. The company attributed the decline to lower property revaluation gains, which fell to NZ$16.8 million from NZ$60.9 million. It said valuations were largely stable during the first half. The comparison shows that lower revaluation gains weighed on comprehensive income despite growth in underlying earnings and improved care metrics. Performance therefore differed depending on the measure, with underlying operating earnings rising and gains related to property valuations declining.

Operating costs were NZ$118.5 million, down 9.6%, with the company saying part of the decline reflected the sale of 7 sites in the previous fiscal year. On a like-for-like basis, costs fell 0.7%. Oceania said it had achieved annualised structural savings of NZ$20.4 million from its fiscal 2026 programme. The company is targeting further cost and cash flow savings during fiscal 2027, as part of a goal of about NZ$30 million. Management linked these savings to its efforts to improve cash flow from the existing business.

Cash flow from the existing business remained positive in October, taking the inflow since the start of the fiscal year to NZ$4.3 million, according to the company’s announcement. The board did not declare an interim distribution. The distribution policy targets 40–60% of free cash flow from operations, which was NZ$1.3 million in the first half. Looking ahead, the company said it was proceeding with the delivery of 81 new units during the second half of fiscal 2027 across four sites. The first deliveries at Elmwood began in November 2026.